Genpact (NYSE:G - Get Free Report) is anticipated to announce its Q2 2025 earnings results after the market closes on Thursday, August 7th. Analysts expect the company to announce earnings of $0.85 per share and revenue of $1.23 billion for the quarter. Genpact has set its Q2 2025 guidance at 0.840-0.860 EPS and its FY 2025 guidance at 3.410-3.520 EPS.
Genpact (NYSE:G - Get Free Report) last issued its earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.04. Genpact had a return on equity of 22.35% and a net margin of 10.88%. The firm had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.21 billion. During the same period in the previous year, the company posted $0.73 earnings per share. The business's revenue was up 7.4% on a year-over-year basis. On average, analysts expect Genpact to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Genpact Stock Performance
Shares of NYSE:G traded up $0.11 during midday trading on Monday, reaching $42.60. 1,164,628 shares of the company traded hands, compared to its average volume of 1,568,119. The company has a quick ratio of 2.45, a current ratio of 2.45 and a debt-to-equity ratio of 0.48. Genpact has a 12 month low of $32.18 and a 12 month high of $56.76. The firm has a market capitalization of $7.45 billion, a price-to-earnings ratio of 14.53, a price-to-earnings-growth ratio of 1.61 and a beta of 0.92. The firm's fifty day moving average price is $43.97 and its two-hundred day moving average price is $47.23.
Genpact Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Thursday, September 11th will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.6%. The ex-dividend date is Thursday, September 11th. Genpact's payout ratio is presently 23.21%.
Analyst Ratings Changes
G has been the topic of a number of analyst reports. Mizuho boosted their price objective on Genpact from $48.00 to $51.00 and gave the company a "neutral" rating in a research note on Tuesday, July 1st. Needham & Company LLC restated a "buy" rating and set a $50.00 target price on shares of Genpact in a research report on Monday, June 30th. Deutsche Bank Aktiengesellschaft began coverage on Genpact in a research report on Thursday, July 17th. They set a "hold" rating and a $47.00 target price for the company. Robert W. Baird reduced their target price on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research report on Thursday, May 8th. Finally, Wall Street Zen upgraded Genpact from a "buy" rating to a "strong-buy" rating in a report on Friday, June 6th. Five analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $49.75.
View Our Latest Stock Report on Genpact
Insiders Place Their Bets
In related news, Director Nicholas C. Gangestad bought 2,000 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The stock was bought at an average cost of $43.97 per share, for a total transaction of $87,940.00. Following the acquisition, the director directly owned 2,000 shares of the company's stock, valued at $87,940. The trade was a ∞ increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.80% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Genpact
Several institutional investors have recently bought and sold shares of the stock. Goldman Sachs Group Inc. raised its position in Genpact by 20.8% during the 1st quarter. Goldman Sachs Group Inc. now owns 353,074 shares of the business services provider's stock valued at $17,788,000 after purchasing an additional 60,887 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Genpact by 12.4% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 511,627 shares of the business services provider's stock valued at $25,776,000 after purchasing an additional 56,557 shares during the last quarter. Royal Bank of Canada raised its position in Genpact by 19.7% during the 1st quarter. Royal Bank of Canada now owns 121,705 shares of the business services provider's stock valued at $6,131,000 after purchasing an additional 20,043 shares during the last quarter. Amundi bought a new position in Genpact during the 1st quarter valued at approximately $58,000. Finally, Focus Partners Wealth lifted its stake in shares of Genpact by 10.3% in the 1st quarter. Focus Partners Wealth now owns 5,227 shares of the business services provider's stock valued at $263,000 after purchasing an additional 488 shares during the period. 96.03% of the stock is currently owned by hedge funds and other institutional investors.
Genpact Company Profile
(
Get Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Stories

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.